Periodontal Disease Treatment Market

The report "Periodontal Disease Treatment Market By Disease Type (Gingivitis, Aggressive Periodontitis, Chronic Periodontitis), Treatment Type (Flap surgery, Root Planning, Bone Grafting,), End User (Dental Hospitals & Dental Clinics) - Global Forecast to 2030", is valued at an estimated USD 2.58 billion in 2024. The size is projected to reach USD 3.63 billion by 2030, at a CAGR of 5.9%. The growth in the Periodontal Disease Treatment market contributed through technological advancements substantially to the growth of the market. Advances such as laser therapy, advanced antimicrobial treatment, and biomaterials for tissue regeneration have improved the treatment efficacy and the results of patients who are undergoing periodontal care. Such advances included expanding treatment options toward more effective and minimally invasive solutions for patients and practitioners alike. More importantly, a rise in the health care spends and dental insurance coverage across many regions has significantly increased the accesses to periodontal care, which is favoring growth in the market. Increased efforts by the governments to improve oral health, as well as the rising number of specialized dental clinics and providers, are increasing the market as well. Shift towards preventive care and immense demand for cosmetic dental interventions that includes the treatments of gum aesthetics increased the market potential.

Browse 300 market data Tables and 60 Figures spread through 320 Pages and in-depth TOC on "Periodontal Disease Treatment Market By Disease Type (Gingivitis, Aggressive Periodontitis, Chronic Periodontitis), Treatment Type (Flap surgery, Root Planning, Bone Grafting,), End User (Dental Hospitals & Dental Clinics) - Global Forecast to 2030"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/periodontal-disease-treatment-market-84851649.html

By disease type, Chronic Periodontitis segment is the second highest segment in the Periodontal Disease Treatment market in 2023.

Based on disease type, the Periodontal Disease Treatment market is segmented into gingivitis, chronic periodontitis, aggressive periodontitis and others. Among these, in 2023, the chronic periodontitis segment is the second highest segment in the Periodontal Disease Treatment market in 2023. The advances in diagnostic tools and technologies, including biomarkers and imaging techniques to detect the disease early, are also fueling this market. Advances enable earlier intervention to better manage chronic periodontitis before such interventions become less effective during the later stages of the disease. Demand is also driven by increasing awareness on both sides of the doctor-patient axis regarding the long-term sequelae associated with untreated periodontitis, including tooth loss and its association with systemic diseases, primarily cardiovascular disease. Also, the rise of non-invasive and minimally invasive treatments, like laser therapy and antimicrobial treatments, may attract patients who look forward to less pain and quicker recovery periods, which are factors fostering the growth of the segment. Also, because of reimbursement for periodontal treatments in most regions and improvements in therapeutic agents that target chronic inflammation, the market for chronic periodontitis management will grow.

By end user, hospitals is holding the largest share in the Periodontal Disease Treatment market in 2023.

Based on end user, the Periodontal Disease Treatment market is segmented into hospitals, DSOs and independent clinics and academic and research institutes. Among these hospitals is holding the largest share in the Periodontal Disease Treatment market in 2023. This is due to Hospitals have been used as referral centers for patients requiring more intensive treatment than can be managed in dental clinics. Besides, with multidisciplinary teams of periodontists, oral surgeons, among other specialists available in hospitals, their patients reap a lot in terms of outcomes. Presently, technology is part and parcel of most hospitals, where high-tech imaging for determining the extent of disease and laser therapy for precise treatments are being made use. This trend of dental tourism has also been benefiting the hospitals by enhancing the patients seeking higher-quality periodontal treatments at competitive prices. This has further led to an increase in the growth of the hospital-based services in the periodontal disease market.

North America dominates the global Periodontal Disease Treatment market in 2023.

The Periodontal Disease Treatment market is segmented into five major regional segments, namely, North America, Europe, Asia Pacific, Latin America and Middle East and Africa. The North America region accounts for the largest share in the Periodontal Disease Treatment market in 2023, The Asia-Pacific region, particularly, is witnessing great development in the treatment of periodontal diseases in the market. This is owing to several factors - oral health awareness that is growing, a rising population of diseases, and the development of new infrastructures related to healthcare. China, India, and Japan headed this development stage accompanied by immense populations and the accumulation of dental disease burden due to the aging of populations and other unhealthy lifestyles. The increasing population of middle-class individuals along with their increased disposable income have further added to the burden of the demand for advanced dental care treatments, including periodontal diseases. Improved accessibility of healthcare via government initiatives combined with the incorporation of advanced technologies like laser therapy and non-surgical treatments has been an integral part of this region's development in the market.

Prominent players in the Periodontal Disease Treatment market include, - DENTSPLY SIRONA Inc. (US), Envista Holdings Corporation (US), A-dec Inc. (US), J. MORITA CORP. (Japan), Straumann Group (Switzerland), BIOLASE, Inc. (US), BEGO GmbH & Co. KG (Germany), Ultradent Products, Inc. (US), Yoshida Dental MFG. Co., Ltd. (Japan), Nakanishi Inc. (Japan), DentalEZ, Inc. (US), Geistlich Pharma AG (Switzerland), Nova Instruments (UK), NewTom (Italy), Millennium Dental Technologies, Inc. (US), PreXion, Inc. (Japan), Brasseler USA (US), AMD Lasers (US), and Bien-Air Dental (US).

Don’t miss out on business opportunities in Periodontal Disease Treatment Market. Speak to our analyst and gain crucial industry insights that will help your business grow.

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
[email protected]